These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29944928)

  • 1. Neutralization of macrophage migration inhibitory factor improves host survival after Clostridium difficile infection.
    Jose S; Mukherjee A; Abhyankar MM; Leng L; Bucala R; Sharma D; Madan R
    Anaerobe; 2018 Oct; 53():56-63. PubMed ID: 29944928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile-induced colitis in mice is independent of leukotrienes.
    Trindade BC; Theriot CM; Leslie JL; Carlson PE; Bergin IL; Peters-Golden M; Young VB; Aronoff DM
    Anaerobe; 2014 Dec; 30():90-8. PubMed ID: 25230329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis.
    Wang L; Cao J; Li C; Zhang L
    J Infect Dis; 2018 Jan; 217(2):198-207. PubMed ID: 29140433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During
    Costa DVS; Moura-Neto V; Bolick DT; Guerrant RL; Fawad JA; Shin JH; Medeiros PHQS; Ledwaba SE; Kolling GL; Martins CS; Venkataraman V; Warren CA; Brito GAC
    Front Cell Infect Microbiol; 2021; 11():739874. PubMed ID: 34568098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.
    Coffing H; Priyamvada S; Anbazhagan AN; Salibay C; Engevik M; Versalovic J; Yacyshyn MB; Yacyshyn B; Tyagi S; Saksena S; Gill RK; Alrefai WA; Dudeja PK
    Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G43-G52. PubMed ID: 29597352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of toxins in Clostridium difficile infection.
    Chandrasekaran R; Lacy DB
    FEMS Microbiol Rev; 2017 Nov; 41(6):723-750. PubMed ID: 29048477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse relapse model of Clostridium difficile infection.
    Sun X; Wang H; Zhang Y; Chen K; Davis B; Feng H
    Infect Immun; 2011 Jul; 79(7):2856-64. PubMed ID: 21576341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
    Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
    PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.
    Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR
    PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
    Sun X; Hirota SA
    Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.
    Andersson JA; Peniche AG; Galindo CL; Boonma P; Sha J; Luna RA; Savidge TC; Chopra AK; Dann SM
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection.
    Zackular JP; Moore JL; Jordan AT; Juttukonda LJ; Noto MJ; Nicholson MR; Crews JD; Semler MW; Zhang Y; Ware LB; Washington MK; Chazin WJ; Caprioli RM; Skaar EP
    Nat Med; 2016 Nov; 22(11):1330-1334. PubMed ID: 27668938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 17. Outbreak of Murine Infection with
    Mau T; Eckley SS; Bergin IL; Saund K; Villano JS; Vendrov KC; Snitkin ES; Young VB; Yung R
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30894434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Leptin Receptor Q223R Polymorphism on Clostridioides difficile Infection-Induced Macrophage Migration Inhibitory Factor Production.
    Mathew AM; Huber A; Sous RD; Weghorn KN; Powers-Fletcher MV; Jose S; Madan R
    J Infect Dis; 2024 Oct; 230(4):816-820. PubMed ID: 38687212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.
    McDonald JAK; Mullish BH; Pechlivanis A; Liu Z; Brignardello J; Kao D; Holmes E; Li JV; Clarke TB; Thursz MR; Marchesi JR
    Gastroenterology; 2018 Nov; 155(5):1495-1507.e15. PubMed ID: 30025704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Toll-Like Receptor-2 in
    Lai YH; Tsai BY; Hsu CY; Chen YH; Chou PH; Chen YL; Liu HC; Ko WC; Tsai PJ; Hung YP
    Front Immunol; 2021; 12():691039. PubMed ID: 34322122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.